The docking results reveal that among the four ligands ((1), BEFVEQ, HOTYAR and JOVWEW) tested against the cancer-related GPCRs, (1) demonstrated the strongest binding affinities, particularly with TBXA2R (−7.59 kcal mol−1) in first rank, then, BEFVEQ also showed notable binding to TBXA2R (−5.85 kcal mol−1). This evidence concerns the gene TBXA2R and cancer.